Cargando...
Targeting the B cell receptor pathway in non-Hodgkin lymphoma
INTRODUCTION: Dysregulated B cell receptor (BCR) signaling has been identified as a potent contributor to tumor survival in B cell non-Hodgkin lymphomas (NHLs). This pathway’s emergence as a rational therapeutic target in NHL led to development of BCR-directed agents, including inhibitors of Bruton’...
Gardado en:
| Publicado en: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6291828/ https://ncbi.nlm.nih.gov/pubmed/29855199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2018.1482273 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|